Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, markets, and sells active pharmaceutical ingredient, intermediates, and finished dosage forms and nutraceuticals for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company offers active pharmaceutical ingredient in various therapeutic categories, including anthelmintic, anti viral, an...
Bajaj HealthCare reported revenue of 6.11 billion INR for fiscal year 2026, up 12.6% from fiscal year 2025, and net income of 157.66 million INR. India was its largest region in fiscal year 2025, with 77% of revenue. Its market capitalization was 10.77 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2026; market data as of October 9, 2026.
No profile data available.